HIGHLIGHTS
- who: Report and colleagues from the (UNIVERSITY) have published the Article: Review began 11/10/2022 Review ended 12/03/2022 Published 12/06/2022 u00a9 Copyright, in the Journal: (JOURNAL) of December/06,/2022
- what: SCBC is an aggressive malignancy.
- future: Investigations are needed to improve the knowledge of the pathophysiology diagnosis and treatment of this rare disease. Checkpoint inhibitors are increasingly evaluated in the neoadjuvant setting of muscle-invasive urothelial bladder cancer with promising results and can be possibly extended for those with non-urothelial variants in the future .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.